Perspective Therapeutics (CATX) Asset Writedowns and Impairment (2016 - 2025)
Perspective Therapeutics (CATX) posted Asset Writedowns and Impairment of $10.0 million for Q4 2025, up 22627.27% sequentially from $44000.0 in Q3 2024.
Perspective Therapeutics (CATX) Asset Writedowns and Impairment (2016 - 2025) Analysis & Trends
Perspective Therapeutics has reported Asset Writedowns and Impairment for 5 years, with the latest figure at $10.0 million in Q4 2025.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $10.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.4 million (up 1452.4% YoY) and the FY2025 annual result came in at $10.0 million, changed N/A from the prior year.
- Asset Writedowns and Impairment advanced to $10.0 million in Q4 2025 per CATX's latest filing, from $44000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $10.0 million in Q4 2025 and troughed at $44000.0 in Q3 2024.
- A 3-year average of $2.2 million and a median of $298000.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
- The widest YoY moves for Asset Writedowns and Impairment: up 85.23% in 2024, down 85.23% in 2024.
- Over 3 years, Asset Writedowns and Impairment stood at $326000.0 in 2023, then sank by 86.5% to $44000.0 in 2024, then soared by 22627.27% to $10.0 million in 2025.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $10.0 million, $44000.0, and $326000.0 for Q4 2025, Q3 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Perspective Therapeutics | 389.10 Mn | 389.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.00 Mn |
| Dec 31, 2025 | 10.00 Mn |
| Sep 30, 2024 | 44,000.00 |
| Sep 30, 2024 | 44,000.00 |
| Dec 31, 2023 | 326,000.00 |
| Dec 31, 2023 | 326,000.00 |
| Sep 30, 2023 | 298,000.00 |
| Sep 30, 2023 | 298,000.00 |
| Jun 30, 2023 | 298,000.00 |
| Jun 30, 2023 | 298,000.00 |
| Jun 30, 2017 | -4,000.00 |
| Jun 30, 2017 | -4,000.00 |
| Mar 31, 2016 | 72,000.00 |
| Mar 31, 2016 | 72,000.00 |